The drug treatment for acute severe asthma has changed little over the past two decades,
comprising primarily of bronchodilators, corticosteroids, and oxygen. Most deaths from acute …

Children who are referred to specialist care with asthma that does not respond to treatment
(problematic severe asthma) are a heterogeneous group, with substantial morbidity. The …

Although most children with asthma are easy to treat with low doses of safe drugs, many
remain symptomatic despite every effort. 1 The nomenclature for this group is confused, and …

Patients with mild persistent asthma rarely see their doctor with symptoms of the disease.
Partly as a result of this situation, mild asthma is generally undertreated. Findings of several …

Comment www. thelancet. com/respiratory Vol 5 November 2017 845 a more accurate term
is asthma-treatment-resistant symptoms. Second, the division between so-called asthma …

Background The mainstay of treatment for acute asthma in children is nebulised β 2-
adrenergic agents such as salbutamol, given with corticosteroids. However, penetration of …

Asthma is an important health care problem; over 12 million people in the United States
suffer from asthma, the majority of whom are young patients. Presentations of acute asthma …

Executive summary Asthma is responsible for considerable global morbidity and health-care
costs. Substantial progress was made against key outcomes such as hospital admissions …

There has been a recent increase in the prevalence of asthma worldwide; however, the 5–
10% of patients with severe disease account for a substantial proportion of the health costs …

Context Asthma is readily diagnosed in most cases and usually responds to inhaled
corticosteroids with or without long-acting β agonists, theophyllines, or leukotriene-receptor …